The introduction of nicotinamide being a nicotine replacement in e-cigarette and smokeless merchandise signifies a significant regulatory problem for that FDA. Nicotinamide does not have nicotinic receptor agonist action and is understood to act as a sedative at significant dosages6. The claims created by Nicotine River, ECBlend, and other vendors